The U.S. Food and Drug Administration (FDA) has approved Recorlev (levoketoconazole) to treat adults with endogenous Cushing’s syndrome for…
Articles by Steve Bryson, PhD
Mutations in the KDM1A gene are responsible for the development of a rare, food-dependent form of Cushing’s syndrome, according to…
CRN04894, a first-in-class, investigational oral medication to treat Cushing’s disease, demonstrated pharmacologic proof-of-concept with a dose-dependent suppression of…
A type of tumor in the brain’s pituitary gland, which causes Cushing’s disease, has been found to be more…
Metopirone (metyrapone) safely and successfully maintained lower levels of urinary cortisol over nine months in…
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Isturisa (osilodrostat)…
Biomarkers in a majority of Cushing’s syndrome patients with surgically induced disease remission showed a high…
A 67-year-old woman developed bone cancer 30 years after receiving radiation therapy to treat Cushing’s…
An alternative diagnostic test to measure the levels of late-night cortisol in the saliva of patients with…
Abnormal fat accumulation, including increased bone marrow fat and insulin resistance, can lead to bone…